Macrophages: Versatile Effectors of Innate and Adaptive Immunity
Macrophages are tissue-resident phagocytes derived from circulating monocytes. They are pivotal in host defense, tissue homeostasis, and immune regulation, exhibiting remarkable plasticity across microenvironments.
Origin & Differentiation
- Bone marrow → monocyte → bloodstream (1–3 days) → extravasation → tissue macrophage.
- Self-renewal in situ (especially embryonically derived: microglia, Kupffer cells, Langerhans cells).
- Monocyte-derived macrophages dominate in inflammation.
Key Tissue-Resident Populations
| Name | Location | Specialized Functions |
|---|
| Kupffer cells | Liver sinusoids | Clear gut-derived toxins, bacteria, endotoxin; iron recycling |
| Alveolar macrophages | Lung alveoli | Surfactant homeostasis, pathogen clearance, tolerate inhaled antigens |
| Microglia | CNS parenchyma | Synaptic pruning, neuroinflammation, amyloid clearance |
| Osteoclasts | Bone | Bone resorption (RANKL-dependent) |
| Splenic red pulp macrophages | Spleen | Erythrocyte clearance, iron recycling, blood-borne pathogen capture |
| Intestinal macrophages | Lamina propria | Tolerance to microbiota, pathogen defense, Treg induction |
Core Functions
- Phagocytosis & Clearance: Opsonin-dependent (FcγR, CR3) and independent (scavenger receptors, Dectin-1). Degrade via phagolysosome (ROS, RNS, hydrolases).
- Antigen Presentation: MHC-II + costimulatory molecules (CD80/86) → activate CD4⁺ T cells. Cross-presentation (MHC-I) for CD8⁺ T cells.
- Cytokine/Chemokine Production: Pro-inflammatory (TNF-α, IL-1β, IL-6, IL-12, IL-23), anti-inflammatory (IL-10, TGF-β), chemokines (CCL2, CXCL8–10).
- Tissue Repair & Remodeling: Growth factors (VEGF, PDGF, TGF-β), matrix metalloproteinases, efferocytosis (apoptotic cell clearance).
- Metabolic Regulation: Adipose tissue macrophages (ATMs) modulate insulin sensitivity; iron handling.
Polarization Spectrum (Simplified)
- M1 (Classically Activated): IFN-γ + LPS → microbicidal, pro-inflammatory, Th1-promoting.
- M2 (Alternatively Activated): IL-4/IL-13 → wound healing, fibrosis, parasite defense, Th2/Treg-promoting.
- In vivo: Continuum, not binary; co-expression common.
Clinical Relevance
- Therapeutic targets: CSF-1R inhibitors (deplete TAMs in cancer), CCR2 antagonists (block monocyte recruitment), CD47 blockade (enhance phagocytosis of tumor cells).
- Biomarkers: CD68, CD163, CD206, HLA-DR, TREM2.
Macrobiotic Diet - Related Articles
